# DESCRIPTION

## FIELD OF THE INVENTION

- introduce death receptor 5 (DR5) and its applications

## BACKGROUND OF THE INVENTION

- introduce death receptors and tumor necrosis factor-related apoptosis inducing ligand (TRAIL)
- describe TRAIL's killing activity on tumor cells
- introduce five natural receptors for TRAIL
- describe decoy receptors and their functions
- discuss the distribution of death receptors in normal and tumor tissues
- introduce the use of TRAIL to induce apoptotic cell death in tumor cells
- discuss the limitations of TRAIL and the potential of agonist monoclonal antibodies
- describe the epitopes recognized by various monoclonal antibodies against DR4 or DR5
- introduce the synergistic effect between TRAIL and AD5-10

## SUMMARY OF THE INVENTION

- introduce the first aspect of the invention: a polypeptide and derivatives thereof
- define the core peptide sequence
- describe the epitope recognized by the monoclonal antibody AD5-10
- introduce the second aspect of the invention: a core peptide and derivatives thereof
- define the amino acid sequence formula
- introduce the third aspect of the invention: a nucleotide sequence encoding for the core peptide
- define the sequence of SEQ ID No: 2
- introduce the fourth aspect of the invention: a method for preparing a monoclonal antibody
- describe the steps of synthesizing the polypeptide sequence
- describe the steps of immunizing a mouse and fusing splenocytes with SP2/0 myeloma cells
- introduce the fifth aspect of the invention: hybridoma cell lines
- describe the hybridoma cell lines Adie-1 and Adie-2
- introduce the sixth aspect of the invention: monoclonal antibodies
- describe the monoclonal antibodies Adie-1 and Adie-2
- introduce the seventh aspect of the invention: uses of the core peptide and derivatives thereof
- describe the uses in the preparation of monoclonal antibodies binding to DR5
- introduce the eighth aspect of the invention: uses of the core peptide and derivatives thereof
- describe the uses in the screening of small molecular compounds
- introduce the ninth and tenth aspects of the invention: uses of the core peptide and derivatives thereof

## DETAILED DESCRIPTION OF THE INVENTION

### Determining the Recognization and Binding of the Monoclonal Antibodies Obtained from the Mice Immunized with the Antigenic Peptides to the Antigenic Peptides and DR5 with Enzyme-Linked Immuno Sorbent Assay (ELISA)

- perform ELISA detection
- illustrate binding activity of supernatants and monoclonal antibodies
- show results in FIG. 1

### The Tumoricidal Activities of TRAIL, AD5-10 and Monoclonal Antibodies Adie-1 and Adie-2 to Human Colon Cancer Cells HCT116

- detect tumoricidal activities with CCK-8

### Detecting the Ability of TRAIL, AD5-10 and Monoclonal Antibodies Adie-1 and Adie-2 to Activate Caspase Cascade Reaction with Western Blotting

- detect caspase cascade reaction with Western Blotting

### The Screening and Identification of Epitopes and Derivatives Thereof Recognized by AD5-10 with Oriented Peptide Array Library Technique

- synthesize derivative peptides
- spot peptide arrays on nitrocellulose membranes
- detect binding capabilities with HRP-conjugated secondary antibodies
- show results in FIG. 4
- determine epitope recognized by AD5-10
- conduct alanine mutation scanning
- construct permutation arrays

### Example 5

- chemically synthesize peptide derivatives
- detect binding ability of synthetic peptides to AD5-10
- show results in FIG. 5
- block tumoricidal activity of AD5-10
- compare effects of wild-type and mutant epitopes
- detect binding ability of AD5-10 to rsTRAIL
- detect binding ability of AD5-10 to DR5 in full length

